Search Results

A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM)

This office is permanently closed. Please call our other breast surgeon offices for assistance: Dr. Plate at 301-933-3216 (Silver Spring area)  Dr. Sen Gupta >240-238-3566 (Rockville area)

KRAS DetECT: KRAS mutation Detection to Evaluate Eligibility for Clinical Trials

A Phase 1/2 Open-Label, Dose-Escalation and Clinical Response Study of Quaratusugene Ozeplasmid in Combination with Osimertinib in Patients with Advanced, EGFR-Mutant, Metastatic Non-Small Cell Lung Cancer who have Progressed after Treatment with Osimertinib (Acclaim-1 Trial)